EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $352,000 | -36.6% | 16,766 | -6.2% | 0.00% | 0.0% |
| Q2 2022 | $555,000 | -24.4% | 17,876 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $734,000 | -5.5% | 17,876 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $777,000 | -59.0% | 17,876 | -52.8% | 0.00% | -75.0% |
| Q3 2021 | $1,894,000 | -20.5% | 37,836 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $2,383,000 | -48.4% | 37,836 | -23.9% | 0.01% | -50.0% |
| Q1 2021 | $4,620,000 | -7.6% | 49,732 | -10.9% | 0.01% | -9.1% |
| Q4 2020 | $4,999,000 | -10.0% | 55,789 | +3.8% | 0.01% | -21.4% |
| Q3 2020 | $5,555,000 | +85.7% | 53,758 | +42.1% | 0.01% | +75.0% |
| Q2 2020 | $2,992,000 | +36.7% | 37,836 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $2,189,000 | +15.8% | 37,836 | +8.0% | 0.01% | +40.0% |
| Q4 2019 | $1,890,000 | – | 35,036 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |